3-Benzyl-6-Bromo-2-Chloroquinoline CAS 654655-68-2 Puritas ≥99.0% (HPLC) Factory
Commercial Supple intermedia:
3-Benzyl-6-Bbromo-2-Mmethoxyquinoline CAS: 654655-69-3
3-Benzyl-6-Bromo-2-Chloroquinoline CAS: 654655-68-2
TMC207 CAS 843663-66-1
CAS: 845533-86-0
| Nomen chemicum | 3-Benzyl-6-Bromo-2-Chloroquinoline |
| Synonyma | 6-Bromo-2-Chloro-3-(Phenylmethyl)quinoline |
| CAS Number | 654655-68-2 |
| CATTUS Number | RF-PI107 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C₁₆H₁₁BrClN |
| M. Pondus | 332.62 |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Alba ad Off-White vel Lux Yellow Pulvis |
| Puritas / Analysis Methodus | ≥99.0% (HPLC) |
| Liquescens punctum | 1000~120.0℃ |
| Humor (KF) | ≤0.50% |
| Requiesce in ignitio | ≤0.50% |
| Totalis immunditias | ≤1.00% |
| Test Standard | Enterprise Standard |
| Consuetudinem | Medium API (CAS: 845533-86-0) |
3-Benzyl-6-bromo-2-Chloroquinoline (CAS: 654655-68-2) principale medium est API (CAS: 845533-86-0).API (CAS: 845533-86-0) est diarylquinonis medicamentum a Janssen pharmaceutico elaboratum.Medicamentum, quod anno 2012 probatum est propter multidrug-obsistentium tuberculosis tractationem (MDR-TB), in societate cum Johnson & Johnson evoluta est, ac primum novum tuberculosis theraphim in quattuor decenniis probatum repraesentat.API (CAS: 845533-86-0) in therapia coniunctione adhibita ad tuberculosis pulmonis multi- pharmaci resistentis curationi per inhibitionem synthaseos ATP, enzyme essentialis ad replicationem mycobacterii.
